Reuters logo
BRIEF-Zubsolv receives authorization for treatment of opioid dependence in Europe
November 20, 2017 / 1:59 PM / a month ago

BRIEF-Zubsolv receives authorization for treatment of opioid dependence in Europe

Nov 20 (Reuters) - Orexo Ab

* Zubsolv receives authorization for treatment of opioid dependence in europe

* Says approval does not trigger any milestone payment. Next milestone payment is expected when the commercialization of Zubsolv is initiated Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below